nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—UGT2B7—Pitavastatin—coronary artery disease	0.0867	0.125	CbGbCtD
Silodosin—UGT2B7—Ezetimibe—coronary artery disease	0.0639	0.0922	CbGbCtD
Silodosin—UGT2B7—Simvastatin—coronary artery disease	0.0594	0.0857	CbGbCtD
Silodosin—UGT2B7—Lovastatin—coronary artery disease	0.0581	0.0839	CbGbCtD
Silodosin—UGT2B7—Atorvastatin—coronary artery disease	0.0529	0.0764	CbGbCtD
Silodosin—UGT2B7—Losartan—coronary artery disease	0.0484	0.0699	CbGbCtD
Silodosin—ABCB1—Ticagrelor—coronary artery disease	0.0275	0.0397	CbGbCtD
Silodosin—ABCB1—Clopidogrel—coronary artery disease	0.017	0.0245	CbGbCtD
Silodosin—ABCB1—Perindopril—coronary artery disease	0.017	0.0245	CbGbCtD
Silodosin—CYP3A4—Ticagrelor—coronary artery disease	0.0165	0.0238	CbGbCtD
Silodosin—ABCB1—Pitavastatin—coronary artery disease	0.0149	0.0214	CbGbCtD
Silodosin—ABCB1—Telmisartan—coronary artery disease	0.0149	0.0214	CbGbCtD
Silodosin—CYP3A4—Fenofibrate—coronary artery disease	0.0147	0.0212	CbGbCtD
Silodosin—ABCB1—Lisinopril—coronary artery disease	0.0141	0.0203	CbGbCtD
Silodosin—ABCB1—Enalapril—coronary artery disease	0.0141	0.0203	CbGbCtD
Silodosin—ABCB1—Timolol—coronary artery disease	0.012	0.0173	CbGbCtD
Silodosin—CYP3A4—Gemfibrozil—coronary artery disease	0.0117	0.017	CbGbCtD
Silodosin—ABCB1—Ezetimibe—coronary artery disease	0.011	0.0158	CbGbCtD
Silodosin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0107	0.0154	CbGbCtD
Silodosin—ABCB1—Captopril—coronary artery disease	0.0105	0.0152	CbGbCtD
Silodosin—CYP3A4—Clopidogrel—coronary artery disease	0.0102	0.0147	CbGbCtD
Silodosin—ABCB1—Simvastatin—coronary artery disease	0.0102	0.0147	CbGbCtD
Silodosin—ABCB1—Pravastatin—coronary artery disease	0.00996	0.0144	CbGbCtD
Silodosin—ABCB1—Lovastatin—coronary artery disease	0.00996	0.0144	CbGbCtD
Silodosin—CYP3A4—Eplerenone—coronary artery disease	0.00947	0.0137	CbGbCtD
Silodosin—ABCB1—Atorvastatin—coronary artery disease	0.00907	0.0131	CbGbCtD
Silodosin—CYP3A4—Enalapril—coronary artery disease	0.00844	0.0122	CbGbCtD
Silodosin—ABCB1—Losartan—coronary artery disease	0.0083	0.012	CbGbCtD
Silodosin—CYP3A4—Rosuvastatin—coronary artery disease	0.00656	0.00947	CbGbCtD
Silodosin—CYP3A4—Ezetimibe—coronary artery disease	0.00656	0.00947	CbGbCtD
Silodosin—CYP3A4—Simvastatin—coronary artery disease	0.0061	0.0088	CbGbCtD
Silodosin—CYP3A4—Lovastatin—coronary artery disease	0.00597	0.00862	CbGbCtD
Silodosin—CYP3A4—Pravastatin—coronary artery disease	0.00597	0.00862	CbGbCtD
Silodosin—CYP3A4—Atorvastatin—coronary artery disease	0.00544	0.00785	CbGbCtD
Silodosin—CYP3A4—Losartan—coronary artery disease	0.00497	0.00718	CbGbCtD
Silodosin—Tamsulosin—HTR7—coronary artery disease	0.00144	1	CrCbGaD
Silodosin—Skin disorder—Furosemide—coronary artery disease	0.000185	0.00101	CcSEcCtD
Silodosin—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000185	0.00101	CcSEcCtD
Silodosin—Asthenia—Lovastatin—coronary artery disease	0.000185	0.00101	CcSEcCtD
Silodosin—Pruritus—Clopidogrel—coronary artery disease	0.000183	0.000998	CcSEcCtD
Silodosin—Hypotension—Perindopril—coronary artery disease	0.000183	0.000998	CcSEcCtD
Silodosin—Insomnia—Captopril—coronary artery disease	0.000183	0.000994	CcSEcCtD
Silodosin—Angiopathy—Lisinopril—coronary artery disease	0.000183	0.000994	CcSEcCtD
Silodosin—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000183	0.000994	CcSEcCtD
Silodosin—Pruritus—Lovastatin—coronary artery disease	0.000182	0.000992	CcSEcCtD
Silodosin—Mediastinal disorder—Lisinopril—coronary artery disease	0.000182	0.000988	CcSEcCtD
Silodosin—Asthenia—Ezetimibe—coronary artery disease	0.000181	0.000986	CcSEcCtD
Silodosin—Shock—Losartan—coronary artery disease	0.000181	0.000985	CcSEcCtD
Silodosin—Gastrointestinal pain—Niacin—coronary artery disease	0.000181	0.000984	CcSEcCtD
Silodosin—Urticaria—Valsartan—coronary artery disease	0.000181	0.000984	CcSEcCtD
Silodosin—Nausea—Rosuvastatin—coronary artery disease	0.000181	0.000982	CcSEcCtD
Silodosin—Diarrhoea—Fenofibrate—coronary artery disease	0.000181	0.000982	CcSEcCtD
Silodosin—Nervous system disorder—Losartan—coronary artery disease	0.00018	0.000982	CcSEcCtD
Silodosin—Urticaria—Olmesartan—coronary artery disease	0.00018	0.000979	CcSEcCtD
Silodosin—Abdominal pain—Valsartan—coronary artery disease	0.00018	0.000979	CcSEcCtD
Silodosin—Tachycardia—Losartan—coronary artery disease	0.00018	0.000977	CcSEcCtD
Silodosin—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000179	0.000976	CcSEcCtD
Silodosin—Abdominal pain—Olmesartan—coronary artery disease	0.000179	0.000974	CcSEcCtD
Silodosin—Pruritus—Ezetimibe—coronary artery disease	0.000179	0.000973	CcSEcCtD
Silodosin—Hypotension—Furosemide—coronary artery disease	0.000178	0.00097	CcSEcCtD
Silodosin—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000178	0.000969	CcSEcCtD
Silodosin—Insomnia—Perindopril—coronary artery disease	0.000177	0.000966	CcSEcCtD
Silodosin—Diarrhoea—Clopidogrel—coronary artery disease	0.000177	0.000965	CcSEcCtD
Silodosin—Asthenia—Eplerenone—coronary artery disease	0.000177	0.000965	CcSEcCtD
Silodosin—Mental disorder—Lisinopril—coronary artery disease	0.000176	0.00096	CcSEcCtD
Silodosin—Diarrhoea—Lovastatin—coronary artery disease	0.000176	0.000959	CcSEcCtD
Silodosin—Urticaria—Niacin—coronary artery disease	0.000176	0.000956	CcSEcCtD
Silodosin—Nausea—Acetylsalicylic acid—coronary artery disease	0.000175	0.000954	CcSEcCtD
Silodosin—Pruritus—Eplerenone—coronary artery disease	0.000175	0.000952	CcSEcCtD
Silodosin—Abdominal pain—Niacin—coronary artery disease	0.000175	0.000952	CcSEcCtD
Silodosin—Dizziness—Fenofibrate—coronary artery disease	0.000174	0.000949	CcSEcCtD
Silodosin—Syncope—Ramipril—coronary artery disease	0.000173	0.000943	CcSEcCtD
Silodosin—Urticaria—Pravastatin—coronary artery disease	0.000173	0.000942	CcSEcCtD
Silodosin—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000173	0.000941	CcSEcCtD
Silodosin—Asthenia—Simvastatin—coronary artery disease	0.000173	0.000941	CcSEcCtD
Silodosin—Diarrhoea—Ezetimibe—coronary artery disease	0.000173	0.000941	CcSEcCtD
Silodosin—Gastrointestinal pain—Enalapril—coronary artery disease	0.000172	0.000937	CcSEcCtD
Silodosin—Abdominal pain—Pravastatin—coronary artery disease	0.000172	0.000937	CcSEcCtD
Silodosin—Hypotension—Losartan—coronary artery disease	0.000172	0.000936	CcSEcCtD
Silodosin—Dizziness—Clopidogrel—coronary artery disease	0.000171	0.000933	CcSEcCtD
Silodosin—Palpitations—Ramipril—coronary artery disease	0.000171	0.00093	CcSEcCtD
Silodosin—Pruritus—Simvastatin—coronary artery disease	0.00017	0.000928	CcSEcCtD
Silodosin—Dizziness—Lovastatin—coronary artery disease	0.00017	0.000927	CcSEcCtD
Silodosin—Loss of consciousness—Ramipril—coronary artery disease	0.00017	0.000925	CcSEcCtD
Silodosin—Gastrointestinal pain—Telmisartan—coronary artery disease	0.00017	0.000925	CcSEcCtD
Silodosin—Syncope—Timolol—coronary artery disease	0.00017	0.000922	CcSEcCtD
Silodosin—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000169	0.000922	CcSEcCtD
Silodosin—Diarrhoea—Eplerenone—coronary artery disease	0.000169	0.000921	CcSEcCtD
Silodosin—Urticaria—Trandolapril—coronary artery disease	0.000168	0.000914	CcSEcCtD
Silodosin—Urticaria—Enalapril—coronary artery disease	0.000167	0.000911	CcSEcCtD
Silodosin—Abdominal pain—Trandolapril—coronary artery disease	0.000167	0.00091	CcSEcCtD
Silodosin—Dizziness—Ezetimibe—coronary artery disease	0.000167	0.000909	CcSEcCtD
Silodosin—Palpitations—Timolol—coronary artery disease	0.000167	0.000909	CcSEcCtD
Silodosin—Abdominal pain—Enalapril—coronary artery disease	0.000167	0.000906	CcSEcCtD
Silodosin—Insomnia—Losartan—coronary artery disease	0.000166	0.000906	CcSEcCtD
Silodosin—Rash—Fenofibrate—coronary artery disease	0.000166	0.000905	CcSEcCtD
Silodosin—Dermatitis—Fenofibrate—coronary artery disease	0.000166	0.000904	CcSEcCtD
Silodosin—Loss of consciousness—Timolol—coronary artery disease	0.000166	0.000904	CcSEcCtD
Silodosin—Headache—Fenofibrate—coronary artery disease	0.000165	0.000899	CcSEcCtD
Silodosin—Gastrointestinal pain—Captopril—coronary artery disease	0.000165	0.000899	CcSEcCtD
Silodosin—Urticaria—Telmisartan—coronary artery disease	0.000165	0.000898	CcSEcCtD
Silodosin—Diarrhoea—Simvastatin—coronary artery disease	0.000165	0.000897	CcSEcCtD
Silodosin—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000165	0.000896	CcSEcCtD
Silodosin—Abdominal pain—Telmisartan—coronary artery disease	0.000164	0.000894	CcSEcCtD
Silodosin—Dizziness—Eplerenone—coronary artery disease	0.000164	0.00089	CcSEcCtD
Silodosin—Rash—Clopidogrel—coronary artery disease	0.000164	0.00089	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000163	0.000889	CcSEcCtD
Silodosin—Dermatitis—Clopidogrel—coronary artery disease	0.000163	0.000889	CcSEcCtD
Silodosin—Asthenia—Valsartan—coronary artery disease	0.000163	0.000888	CcSEcCtD
Silodosin—Asthenia—Olmesartan—coronary artery disease	0.000162	0.000884	CcSEcCtD
Silodosin—Headache—Clopidogrel—coronary artery disease	0.000162	0.000884	CcSEcCtD
Silodosin—Rash—Lovastatin—coronary artery disease	0.000162	0.000884	CcSEcCtD
Silodosin—Dermatitis—Lovastatin—coronary artery disease	0.000162	0.000883	CcSEcCtD
Silodosin—Headache—Lovastatin—coronary artery disease	0.000161	0.000878	CcSEcCtD
Silodosin—Pruritus—Valsartan—coronary artery disease	0.000161	0.000876	CcSEcCtD
Silodosin—Dry mouth—Ramipril—coronary artery disease	0.000161	0.000876	CcSEcCtD
Silodosin—Gastrointestinal pain—Perindopril—coronary artery disease	0.00016	0.000873	CcSEcCtD
Silodosin—Pruritus—Olmesartan—coronary artery disease	0.00016	0.000872	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.00016	0.00087	CcSEcCtD
Silodosin—Abdominal pain—Captopril—coronary artery disease	0.00016	0.000869	CcSEcCtD
Silodosin—Dizziness—Simvastatin—coronary artery disease	0.000159	0.000867	CcSEcCtD
Silodosin—Rash—Ezetimibe—coronary artery disease	0.000159	0.000867	CcSEcCtD
Silodosin—Dermatitis—Ezetimibe—coronary artery disease	0.000159	0.000866	CcSEcCtD
Silodosin—Asthenia—Niacin—coronary artery disease	0.000159	0.000864	CcSEcCtD
Silodosin—Headache—Ezetimibe—coronary artery disease	0.000158	0.000861	CcSEcCtD
Silodosin—Dry mouth—Timolol—coronary artery disease	0.000157	0.000856	CcSEcCtD
Silodosin—Syncope—Lisinopril—coronary artery disease	0.000157	0.000856	CcSEcCtD
Silodosin—Nausea—Fenofibrate—coronary artery disease	0.000157	0.000853	CcSEcCtD
Silodosin—Pruritus—Niacin—coronary artery disease	0.000157	0.000852	CcSEcCtD
Silodosin—Asthenia—Pravastatin—coronary artery disease	0.000156	0.00085	CcSEcCtD
Silodosin—Gastrointestinal pain—Furosemide—coronary artery disease	0.000156	0.000849	CcSEcCtD
Silodosin—Rash—Eplerenone—coronary artery disease	0.000156	0.000848	CcSEcCtD
Silodosin—Urticaria—Perindopril—coronary artery disease	0.000156	0.000848	CcSEcCtD
Silodosin—Dermatitis—Eplerenone—coronary artery disease	0.000156	0.000848	CcSEcCtD
Silodosin—Diarrhoea—Valsartan—coronary artery disease	0.000156	0.000847	CcSEcCtD
Silodosin—Shock—Ramipril—coronary artery disease	0.000155	0.000845	CcSEcCtD
Silodosin—Abdominal pain—Perindopril—coronary artery disease	0.000155	0.000844	CcSEcCtD
Silodosin—Palpitations—Lisinopril—coronary artery disease	0.000155	0.000843	CcSEcCtD
Silodosin—Diarrhoea—Olmesartan—coronary artery disease	0.000155	0.000843	CcSEcCtD
Silodosin—Headache—Eplerenone—coronary artery disease	0.000155	0.000843	CcSEcCtD
Silodosin—Nervous system disorder—Ramipril—coronary artery disease	0.000155	0.000842	CcSEcCtD
Silodosin—Pruritus—Pravastatin—coronary artery disease	0.000154	0.000839	CcSEcCtD
Silodosin—Loss of consciousness—Lisinopril—coronary artery disease	0.000154	0.000839	CcSEcCtD
Silodosin—Nausea—Clopidogrel—coronary artery disease	0.000154	0.000838	CcSEcCtD
Silodosin—Tachycardia—Ramipril—coronary artery disease	0.000154	0.000838	CcSEcCtD
Silodosin—Skin disorder—Ramipril—coronary artery disease	0.000153	0.000834	CcSEcCtD
Silodosin—Nausea—Lovastatin—coronary artery disease	0.000153	0.000833	CcSEcCtD
Silodosin—Rash—Simvastatin—coronary artery disease	0.000152	0.000827	CcSEcCtD
Silodosin—Dermatitis—Simvastatin—coronary artery disease	0.000152	0.000826	CcSEcCtD
Silodosin—Asthenia—Trandolapril—coronary artery disease	0.000152	0.000826	CcSEcCtD
Silodosin—Shock—Timolol—coronary artery disease	0.000152	0.000826	CcSEcCtD
Silodosin—Urticaria—Furosemide—coronary artery disease	0.000152	0.000824	CcSEcCtD
Silodosin—Diarrhoea—Niacin—coronary artery disease	0.000151	0.000824	CcSEcCtD
Silodosin—Nervous system disorder—Timolol—coronary artery disease	0.000151	0.000823	CcSEcCtD
Silodosin—Asthenia—Enalapril—coronary artery disease	0.000151	0.000823	CcSEcCtD
Silodosin—Headache—Simvastatin—coronary artery disease	0.000151	0.000821	CcSEcCtD
Silodosin—Abdominal pain—Furosemide—coronary artery disease	0.000151	0.00082	CcSEcCtD
Silodosin—Gastrointestinal pain—Losartan—coronary artery disease	0.00015	0.000819	CcSEcCtD
Silodosin—Dizziness—Valsartan—coronary artery disease	0.00015	0.000819	CcSEcCtD
Silodosin—Nausea—Ezetimibe—coronary artery disease	0.00015	0.000817	CcSEcCtD
Silodosin—Skin disorder—Timolol—coronary artery disease	0.00015	0.000815	CcSEcCtD
Silodosin—Dizziness—Olmesartan—coronary artery disease	0.00015	0.000815	CcSEcCtD
Silodosin—Pruritus—Trandolapril—coronary artery disease	0.00015	0.000814	CcSEcCtD
Silodosin—Asthenia—Telmisartan—coronary artery disease	0.000149	0.000811	CcSEcCtD
Silodosin—Pruritus—Enalapril—coronary artery disease	0.000149	0.000811	CcSEcCtD
Silodosin—Diarrhoea—Pravastatin—coronary artery disease	0.000149	0.000811	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000148	0.000807	CcSEcCtD
Silodosin—Hypotension—Ramipril—coronary artery disease	0.000147	0.000802	CcSEcCtD
Silodosin—Pruritus—Telmisartan—coronary artery disease	0.000147	0.0008	CcSEcCtD
Silodosin—Nausea—Eplerenone—coronary artery disease	0.000147	0.000799	CcSEcCtD
Silodosin—Dizziness—Niacin—coronary artery disease	0.000146	0.000796	CcSEcCtD
Silodosin—Urticaria—Losartan—coronary artery disease	0.000146	0.000795	CcSEcCtD
Silodosin—Dry mouth—Lisinopril—coronary artery disease	0.000146	0.000794	CcSEcCtD
Silodosin—Abdominal pain—Losartan—coronary artery disease	0.000145	0.000792	CcSEcCtD
Silodosin—Asthenia—Captopril—coronary artery disease	0.000145	0.000789	CcSEcCtD
Silodosin—Diarrhoea—Trandolapril—coronary artery disease	0.000145	0.000788	CcSEcCtD
Silodosin—Diarrhoea—Enalapril—coronary artery disease	0.000144	0.000784	CcSEcCtD
Silodosin—Hypotension—Timolol—coronary artery disease	0.000144	0.000784	CcSEcCtD
Silodosin—Dizziness—Pravastatin—coronary artery disease	0.000144	0.000784	CcSEcCtD
Silodosin—Rash—Valsartan—coronary artery disease	0.000143	0.000781	CcSEcCtD
Silodosin—Dermatitis—Valsartan—coronary artery disease	0.000143	0.00078	CcSEcCtD
Silodosin—Nausea—Simvastatin—coronary artery disease	0.000143	0.000779	CcSEcCtD
Silodosin—Pruritus—Captopril—coronary artery disease	0.000143	0.000778	CcSEcCtD
Silodosin—Rash—Olmesartan—coronary artery disease	0.000143	0.000777	CcSEcCtD
Silodosin—Insomnia—Ramipril—coronary artery disease	0.000143	0.000777	CcSEcCtD
Silodosin—Dermatitis—Olmesartan—coronary artery disease	0.000143	0.000776	CcSEcCtD
Silodosin—Headache—Valsartan—coronary artery disease	0.000143	0.000776	CcSEcCtD
Silodosin—Diarrhoea—Telmisartan—coronary artery disease	0.000142	0.000774	CcSEcCtD
Silodosin—Headache—Olmesartan—coronary artery disease	0.000142	0.000772	CcSEcCtD
Silodosin—Shock—Lisinopril—coronary artery disease	0.000141	0.000766	CcSEcCtD
Silodosin—Asthenia—Perindopril—coronary artery disease	0.000141	0.000766	CcSEcCtD
Silodosin—Dizziness—Trandolapril—coronary artery disease	0.00014	0.000761	CcSEcCtD
Silodosin—Tachycardia—Lisinopril—coronary artery disease	0.00014	0.00076	CcSEcCtD
Silodosin—Insomnia—Timolol—coronary artery disease	0.00014	0.000759	CcSEcCtD
Silodosin—Rash—Niacin—coronary artery disease	0.00014	0.000759	CcSEcCtD
Silodosin—Dermatitis—Niacin—coronary artery disease	0.000139	0.000758	CcSEcCtD
Silodosin—Dizziness—Enalapril—coronary artery disease	0.000139	0.000758	CcSEcCtD
Silodosin—Skin disorder—Lisinopril—coronary artery disease	0.000139	0.000756	CcSEcCtD
Silodosin—Pruritus—Perindopril—coronary artery disease	0.000139	0.000755	CcSEcCtD
Silodosin—Headache—Niacin—coronary artery disease	0.000139	0.000754	CcSEcCtD
Silodosin—Diarrhoea—Captopril—coronary artery disease	0.000138	0.000752	CcSEcCtD
Silodosin—Dizziness—Telmisartan—coronary artery disease	0.000137	0.000748	CcSEcCtD
Silodosin—Rash—Pravastatin—coronary artery disease	0.000137	0.000747	CcSEcCtD
Silodosin—Dermatitis—Pravastatin—coronary artery disease	0.000137	0.000747	CcSEcCtD
Silodosin—Asthenia—Furosemide—coronary artery disease	0.000137	0.000745	CcSEcCtD
Silodosin—Headache—Pravastatin—coronary artery disease	0.000136	0.000743	CcSEcCtD
Silodosin—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000136	0.000741	CcSEcCtD
Silodosin—Nausea—Valsartan—coronary artery disease	0.000135	0.000735	CcSEcCtD
Silodosin—Pruritus—Furosemide—coronary artery disease	0.000135	0.000734	CcSEcCtD
Silodosin—Nausea—Olmesartan—coronary artery disease	0.000135	0.000732	CcSEcCtD
Silodosin—Diarrhoea—Perindopril—coronary artery disease	0.000134	0.00073	CcSEcCtD
Silodosin—Hypotension—Lisinopril—coronary artery disease	0.000134	0.000728	CcSEcCtD
Silodosin—Dizziness—Captopril—coronary artery disease	0.000134	0.000727	CcSEcCtD
Silodosin—Rash—Trandolapril—coronary artery disease	0.000133	0.000726	CcSEcCtD
Silodosin—Dermatitis—Trandolapril—coronary artery disease	0.000133	0.000725	CcSEcCtD
Silodosin—Gastrointestinal disorder—Timolol—coronary artery disease	0.000133	0.000725	CcSEcCtD
Silodosin—Rash—Enalapril—coronary artery disease	0.000133	0.000723	CcSEcCtD
Silodosin—Dermatitis—Enalapril—coronary artery disease	0.000133	0.000722	CcSEcCtD
Silodosin—Headache—Trandolapril—coronary artery disease	0.000133	0.000721	CcSEcCtD
Silodosin—Asthenia—Losartan—coronary artery disease	0.000132	0.000718	CcSEcCtD
Silodosin—Headache—Enalapril—coronary artery disease	0.000132	0.000718	CcSEcCtD
Silodosin—Nausea—Niacin—coronary artery disease	0.000131	0.000715	CcSEcCtD
Silodosin—Rash—Telmisartan—coronary artery disease	0.000131	0.000713	CcSEcCtD
Silodosin—Dermatitis—Telmisartan—coronary artery disease	0.000131	0.000712	CcSEcCtD
Silodosin—Diarrhoea—Furosemide—coronary artery disease	0.000131	0.00071	CcSEcCtD
Silodosin—Pruritus—Losartan—coronary artery disease	0.00013	0.000708	CcSEcCtD
Silodosin—Headache—Telmisartan—coronary artery disease	0.00013	0.000708	CcSEcCtD
Silodosin—Dizziness—Perindopril—coronary artery disease	0.00013	0.000706	CcSEcCtD
Silodosin—Insomnia—Lisinopril—coronary artery disease	0.000129	0.000704	CcSEcCtD
Silodosin—Nausea—Pravastatin—coronary artery disease	0.000129	0.000704	CcSEcCtD
Silodosin—Gastrointestinal pain—Ramipril—coronary artery disease	0.000129	0.000702	CcSEcCtD
Silodosin—Rash—Captopril—coronary artery disease	0.000127	0.000693	CcSEcCtD
Silodosin—Dermatitis—Captopril—coronary artery disease	0.000127	0.000693	CcSEcCtD
Silodosin—Headache—Captopril—coronary artery disease	0.000127	0.000689	CcSEcCtD
Silodosin—Gastrointestinal pain—Timolol—coronary artery disease	0.000126	0.000686	CcSEcCtD
Silodosin—Dizziness—Furosemide—coronary artery disease	0.000126	0.000686	CcSEcCtD
Silodosin—Diarrhoea—Losartan—coronary artery disease	0.000126	0.000685	CcSEcCtD
Silodosin—Nausea—Trandolapril—coronary artery disease	0.000126	0.000684	CcSEcCtD
Silodosin—Urticaria—Ramipril—coronary artery disease	0.000125	0.000682	CcSEcCtD
Silodosin—Nausea—Enalapril—coronary artery disease	0.000125	0.000681	CcSEcCtD
Silodosin—Abdominal pain—Ramipril—coronary artery disease	0.000125	0.000679	CcSEcCtD
Silodosin—Rash—Perindopril—coronary artery disease	0.000124	0.000673	CcSEcCtD
Silodosin—Dermatitis—Perindopril—coronary artery disease	0.000124	0.000672	CcSEcCtD
Silodosin—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000124	0.000672	CcSEcCtD
Silodosin—Nausea—Telmisartan—coronary artery disease	0.000123	0.000672	CcSEcCtD
Silodosin—Headache—Perindopril—coronary artery disease	0.000123	0.000669	CcSEcCtD
Silodosin—Urticaria—Timolol—coronary artery disease	0.000123	0.000667	CcSEcCtD
Silodosin—Abdominal pain—Timolol—coronary artery disease	0.000122	0.000664	CcSEcCtD
Silodosin—Dizziness—Losartan—coronary artery disease	0.000122	0.000662	CcSEcCtD
Silodosin—Rash—Furosemide—coronary artery disease	0.00012	0.000654	CcSEcCtD
Silodosin—Dermatitis—Furosemide—coronary artery disease	0.00012	0.000654	CcSEcCtD
Silodosin—Nausea—Captopril—coronary artery disease	0.00012	0.000653	CcSEcCtD
Silodosin—Headache—Furosemide—coronary artery disease	0.000119	0.00065	CcSEcCtD
Silodosin—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000117	0.000637	CcSEcCtD
Silodosin—Nausea—Perindopril—coronary artery disease	0.000117	0.000634	CcSEcCtD
Silodosin—Rash—Losartan—coronary artery disease	0.000116	0.000631	CcSEcCtD
Silodosin—Dermatitis—Losartan—coronary artery disease	0.000116	0.000631	CcSEcCtD
Silodosin—Headache—Losartan—coronary artery disease	0.000115	0.000627	CcSEcCtD
Silodosin—Urticaria—Lisinopril—coronary artery disease	0.000114	0.000619	CcSEcCtD
Silodosin—Nausea—Furosemide—coronary artery disease	0.000113	0.000616	CcSEcCtD
Silodosin—Asthenia—Ramipril—coronary artery disease	0.000113	0.000616	CcSEcCtD
Silodosin—Abdominal pain—Lisinopril—coronary artery disease	0.000113	0.000616	CcSEcCtD
Silodosin—Pruritus—Ramipril—coronary artery disease	0.000112	0.000607	CcSEcCtD
Silodosin—Asthenia—Timolol—coronary artery disease	0.000111	0.000602	CcSEcCtD
Silodosin—Nausea—Losartan—coronary artery disease	0.000109	0.000595	CcSEcCtD
Silodosin—Pruritus—Timolol—coronary artery disease	0.000109	0.000594	CcSEcCtD
Silodosin—Diarrhoea—Ramipril—coronary artery disease	0.000108	0.000587	CcSEcCtD
Silodosin—Diarrhoea—Timolol—coronary artery disease	0.000106	0.000574	CcSEcCtD
Silodosin—Dizziness—Ramipril—coronary artery disease	0.000104	0.000568	CcSEcCtD
Silodosin—Asthenia—Lisinopril—coronary artery disease	0.000103	0.000559	CcSEcCtD
Silodosin—Dizziness—Timolol—coronary artery disease	0.000102	0.000555	CcSEcCtD
Silodosin—Pruritus—Lisinopril—coronary artery disease	0.000101	0.000551	CcSEcCtD
Silodosin—Rash—Ramipril—coronary artery disease	9.95e-05	0.000541	CcSEcCtD
Silodosin—Dermatitis—Ramipril—coronary artery disease	9.94e-05	0.000541	CcSEcCtD
Silodosin—Headache—Ramipril—coronary artery disease	9.89e-05	0.000538	CcSEcCtD
Silodosin—Diarrhoea—Lisinopril—coronary artery disease	9.79e-05	0.000533	CcSEcCtD
Silodosin—Rash—Timolol—coronary artery disease	9.73e-05	0.000529	CcSEcCtD
Silodosin—Dermatitis—Timolol—coronary artery disease	9.72e-05	0.000529	CcSEcCtD
Silodosin—Headache—Timolol—coronary artery disease	9.66e-05	0.000526	CcSEcCtD
Silodosin—Dizziness—Lisinopril—coronary artery disease	9.46e-05	0.000515	CcSEcCtD
Silodosin—Nausea—Ramipril—coronary artery disease	9.37e-05	0.00051	CcSEcCtD
Silodosin—Nausea—Timolol—coronary artery disease	9.16e-05	0.000499	CcSEcCtD
Silodosin—Rash—Lisinopril—coronary artery disease	9.02e-05	0.000491	CcSEcCtD
Silodosin—Dermatitis—Lisinopril—coronary artery disease	9.02e-05	0.000491	CcSEcCtD
Silodosin—Headache—Lisinopril—coronary artery disease	8.97e-05	0.000488	CcSEcCtD
Silodosin—Nausea—Lisinopril—coronary artery disease	8.5e-05	0.000463	CcSEcCtD
Silodosin—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.06e-06	4.96e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCLM—coronary artery disease	6.06e-06	4.96e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	6e-06	4.92e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	6e-06	4.92e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOE—coronary artery disease	5.99e-06	4.91e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LEP—coronary artery disease	5.99e-06	4.91e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	5.99e-06	4.91e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSMA6—coronary artery disease	5.98e-06	4.9e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSMB5—coronary artery disease	5.98e-06	4.9e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CSF2—coronary artery disease	5.98e-06	4.9e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FGF1—coronary artery disease	5.98e-06	4.9e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—S100B—coronary artery disease	5.97e-06	4.9e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LPL—coronary artery disease	5.94e-06	4.87e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOA1—coronary artery disease	5.93e-06	4.86e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	5.92e-06	4.85e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RPS6KB1—coronary artery disease	5.88e-06	4.82e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MEF2C—coronary artery disease	5.88e-06	4.82e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KDR—coronary artery disease	5.87e-06	4.81e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP11B2—coronary artery disease	5.86e-06	4.81e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TXNRD1—coronary artery disease	5.86e-06	4.81e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	5.85e-06	4.79e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	5.85e-06	4.79e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CTGF—coronary artery disease	5.84e-06	4.79e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK14—coronary artery disease	5.83e-06	4.78e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GOT2—coronary artery disease	5.79e-06	4.75e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMGCR—coronary artery disease	5.79e-06	4.75e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.78e-06	4.74e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ITGB3—coronary artery disease	5.73e-06	4.7e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ESR1—coronary artery disease	5.72e-06	4.69e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	5.71e-06	4.68e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	5.71e-06	4.68e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HADH—coronary artery disease	5.69e-06	4.67e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.69e-06	4.67e-05	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	5.68e-06	4.65e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FN1—coronary artery disease	5.65e-06	4.63e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—F2—coronary artery disease	5.65e-06	4.63e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6ST—coronary artery disease	5.63e-06	4.62e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCL8—coronary artery disease	5.6e-06	4.59e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NFKBIA—coronary artery disease	5.59e-06	4.58e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PPP2CA—coronary artery disease	5.57e-06	4.57e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOB—coronary artery disease	5.52e-06	4.53e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	5.47e-06	4.49e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PRKCD—coronary artery disease	5.47e-06	4.48e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	5.45e-06	4.47e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	5.43e-06	4.45e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KIT—coronary artery disease	5.41e-06	4.44e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA2—coronary artery disease	5.4e-06	4.42e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX2—coronary artery disease	5.4e-06	4.42e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.4e-06	4.42e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	5.39e-06	4.42e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR2A—coronary artery disease	5.35e-06	4.39e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—C3—coronary artery disease	5.34e-06	4.38e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HK1—coronary artery disease	5.33e-06	4.37e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.33e-06	4.37e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX4—coronary artery disease	5.33e-06	4.37e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.33e-06	4.37e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PLCB1—coronary artery disease	5.33e-06	4.37e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	5.31e-06	4.35e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	5.31e-06	4.35e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LPL—coronary artery disease	5.27e-06	4.32e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HADHA—coronary artery disease	5.27e-06	4.32e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	5.23e-06	4.28e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	5.23e-06	4.28e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.21e-06	4.27e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GSK3B—coronary artery disease	5.19e-06	4.26e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ABCA1—coronary artery disease	5.16e-06	4.23e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—POMC—coronary artery disease	5.15e-06	4.22e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CREB1—coronary artery disease	5.15e-06	4.22e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPA—coronary artery disease	5.15e-06	4.22e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	5.1e-06	4.18e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	5.09e-06	4.17e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGT—coronary artery disease	5.08e-06	4.16e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCL2—coronary artery disease	5.04e-06	4.13e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6R—coronary artery disease	5.02e-06	4.12e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GGT1—coronary artery disease	5e-06	4.1e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GOT1—coronary artery disease	5e-06	4.1e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.99e-06	4.09e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOE—coronary artery disease	4.98e-06	4.08e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LEP—coronary artery disease	4.98e-06	4.08e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	4.97e-06	4.08e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF1—coronary artery disease	4.95e-06	4.06e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	4.95e-06	4.06e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA5—coronary artery disease	4.94e-06	4.05e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—MAPK1—coronary artery disease	4.93e-06	4.04e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	4.92e-06	4.03e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KDR—coronary artery disease	4.87e-06	4e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	4.86e-06	3.98e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	4.84e-06	3.97e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—P4HB—coronary artery disease	4.84e-06	3.97e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	4.75e-06	3.9e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.75e-06	3.9e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	4.75e-06	3.89e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—C3—coronary artery disease	4.75e-06	3.89e-05	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CA—coronary artery disease	4.71e-06	3.86e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SERPINE1—coronary artery disease	4.7e-06	3.86e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—F2—coronary artery disease	4.69e-06	3.85e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FN1—coronary artery disease	4.69e-06	3.85e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	4.67e-06	3.83e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	4.64e-06	3.8e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	4.55e-06	3.73e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	4.53e-06	3.71e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGT—coronary artery disease	4.51e-06	3.7e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTP1—coronary artery disease	4.49e-06	3.68e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	4.49e-06	3.68e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KIT—coronary artery disease	4.49e-06	3.68e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—VCAN—coronary artery disease	4.48e-06	3.67e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	4.45e-06	3.65e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.44e-06	3.64e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—coronary artery disease	4.43e-06	3.63e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LEP—coronary artery disease	4.42e-06	3.62e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOE—coronary artery disease	4.42e-06	3.62e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CAT—coronary artery disease	4.37e-06	3.58e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	4.37e-06	3.58e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	4.36e-06	3.58e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KDR—coronary artery disease	4.33e-06	3.55e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—DCN—coronary artery disease	4.31e-06	3.54e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	4.31e-06	3.53e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	4.3e-06	3.53e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	4.28e-06	3.51e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—POMC—coronary artery disease	4.27e-06	3.5e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	4.27e-06	3.5e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOB—coronary artery disease	4.24e-06	3.48e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	4.22e-06	3.46e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.2e-06	3.44e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	4.18e-06	3.43e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	4.17e-06	3.42e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—F2—coronary artery disease	4.17e-06	3.42e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FN1—coronary artery disease	4.17e-06	3.42e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	4.15e-06	3.4e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTM1—coronary artery disease	4.13e-06	3.38e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	4.12e-06	3.38e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	4.11e-06	3.37e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	4.09e-06	3.35e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.09e-06	3.35e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.09e-06	3.35e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HBA1—coronary artery disease	4.09e-06	3.35e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LIPC—coronary artery disease	4.09e-06	3.35e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOC3—coronary artery disease	4.06e-06	3.33e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LPL—coronary artery disease	4.05e-06	3.32e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LDLR—coronary artery disease	4.04e-06	3.31e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.99e-06	3.27e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.99e-06	3.27e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KIT—coronary artery disease	3.99e-06	3.27e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	3.98e-06	3.27e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPX1—coronary artery disease	3.95e-06	3.24e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCLC—coronary artery disease	3.95e-06	3.23e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CETP—coronary artery disease	3.95e-06	3.23e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	3.91e-06	3.21e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	3.9e-06	3.2e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SDC1—coronary artery disease	3.9e-06	3.2e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CD36—coronary artery disease	3.85e-06	3.16e-05	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	3.85e-06	3.15e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CA—coronary artery disease	3.84e-06	3.15e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	3.83e-06	3.14e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	3.81e-06	3.13e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPP2CA—coronary artery disease	3.8e-06	3.12e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—POMC—coronary artery disease	3.8e-06	3.11e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	3.8e-06	3.11e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	3.79e-06	3.11e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	3.78e-06	3.1e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	3.73e-06	3.06e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	3.71e-06	3.05e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	3.71e-06	3.04e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	3.7e-06	3.04e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.69e-06	3.02e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.69e-06	3.02e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	3.65e-06	2.99e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—coronary artery disease	3.65e-06	2.99e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	3.63e-06	2.98e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	3.62e-06	2.97e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	3.6e-06	2.95e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CTGF—coronary artery disease	3.6e-06	2.95e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.57e-06	2.93e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GOT2—coronary artery disease	3.57e-06	2.93e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	3.55e-06	2.91e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	3.49e-06	2.86e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.47e-06	2.85e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	3.47e-06	2.84e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AGT—coronary artery disease	3.47e-06	2.84e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOE—coronary artery disease	3.4e-06	2.78e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	3.36e-06	2.75e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOA1—coronary artery disease	3.36e-06	2.75e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	3.31e-06	2.71e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	3.31e-06	2.71e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.28e-06	2.69e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	3.24e-06	2.65e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	3.22e-06	2.64e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	3.19e-06	2.62e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.18e-06	2.61e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	3.16e-06	2.59e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.15e-06	2.59e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	3.14e-06	2.58e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKT1—coronary artery disease	3.14e-06	2.57e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GGT1—coronary artery disease	3.08e-06	2.53e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GOT1—coronary artery disease	3.08e-06	2.53e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	3.08e-06	2.53e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	2.99e-06	2.45e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	2.97e-06	2.43e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARG—coronary artery disease	2.96e-06	2.42e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	2.94e-06	2.41e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—POMC—coronary artery disease	2.92e-06	2.39e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	2.91e-06	2.39e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	2.9e-06	2.38e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	2.84e-06	2.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	2.81e-06	2.3e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	2.79e-06	2.29e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.77e-06	2.27e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.74e-06	2.25e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	2.74e-06	2.24e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.73e-06	2.24e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CAT—coronary artery disease	2.69e-06	2.21e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	2.69e-06	2.2e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALB—coronary artery disease	2.66e-06	2.18e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	2.66e-06	2.18e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOB—coronary artery disease	2.61e-06	2.14e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	2.58e-06	2.11e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NOS3—coronary artery disease	2.54e-06	2.09e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.54e-06	2.08e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	2.53e-06	2.07e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPL—coronary artery disease	2.5e-06	2.05e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	2.46e-06	2.02e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX1—coronary artery disease	2.44e-06	2e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	2.42e-06	1.98e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	2.39e-06	1.96e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CD36—coronary artery disease	2.37e-06	1.94e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.34e-06	1.92e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—coronary artery disease	2.33e-06	1.91e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.25e-06	1.84e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—coronary artery disease	2.24e-06	1.83e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	2.19e-06	1.79e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	2.15e-06	1.76e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AGT—coronary artery disease	2.14e-06	1.75e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	2.1e-06	1.72e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOE—coronary artery disease	2.09e-06	1.72e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA1—coronary artery disease	2.07e-06	1.7e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	2.06e-06	1.69e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	1.86e-06	1.53e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—coronary artery disease	1.86e-06	1.52e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARG—coronary artery disease	1.82e-06	1.49e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—POMC—coronary artery disease	1.8e-06	1.47e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	1.71e-06	1.4e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—coronary artery disease	1.65e-06	1.35e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALB—coronary artery disease	1.64e-06	1.34e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NOS3—coronary artery disease	1.57e-06	1.28e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	1.52e-06	1.25e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.43e-06	1.18e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.43e-06	1.17e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKT1—coronary artery disease	1.17e-06	9.59e-06	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	8.82e-07	7.23e-06	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKT1—coronary artery disease	7.21e-07	5.91e-06	CbGpPWpGaD
